Stage 1 Hypertension and the 10‐Year and Lifetime Risk of Cardiovascular Disease: A Prospective Real‐World Study

Stage 1 Hypertension and the 10‐Year and Lifetime Risk of Cardiovascular Disease: A Prospective Real‐World Study

Background The 10‐year and lifetime cardiovascular disease risk in the population with stage 1 hypertension and the effects of recovery from and progression of stage 1 hypertension remain undetermined. Methods and Results This prospective cohort study included 96 268 individuals with blood pressure...

Full description

Bibliographic Details
Main Authors:	Xinyi Peng, Cheng Jin, Qirui Song, Shouling Wu, Jun Cai
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	cardiovascular disease hypertension lifetime risk real‐world study stage 1 hypertension
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.122.028762

Similar Items

Age-specific association of stage of hypertension at diagnosis with cardiovascular and all-cause mortality among elderly patients with hypertension: a cohort study
by: Jingyi Wu, et al.
Published: (2023-05-01)

Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies
by: Nick H. Kim, et al.
Published: (2024-01-01)

The Use of Aspirin Increases the Risk of Major Adverse Cardiac and Cerebrovascular Events in Hypertensive Patients with Obstructive Sleep Apnea for the Primary Prevention of Cardiovascular Disease: A Real-World Cohort Study
by: Nanfang Li, et al.
Published: (2022-11-01)

Orthostatic hypertension in cardiovascular risk stratification in hypertensive patients
by: E. Yu. Gubareva, et al.
Published: (2021-04-01)

Ideal Cardiovascular Health Metric and Its Change With Lifetime Risk of Cardiovascular Diseases: A Prospective Cohort Study
by: Lulin Wang, et al.
Published: (2021-11-01)

Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study
by: Renren Yang, et al.
Published: (2023-12-01)

Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO)
by: Il Suk Sohn, et al.
Published: (2021-11-01)

Evaluation of transitions from early hypertension to hypertensive chronic kidney disease, coronary artery disease, stroke and mortality: a Thai real-world data cohort
by: Htun Teza, et al.
Published: (2023-05-01)

Cardiovascular implications in adolescent and young adult hypertension
by: Rupesh Raina, et al.
Published: (2022-05-01)

Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real‐world patient data repository
by: Harrison W. Farber, et al.
Published: (2023-07-01)

Physicians' estimates of the 10 year cardiovascular risk in hypertensive patients: An evaluation in primary care physicians in training
by: M Senn
Published: (2006-09-01)

Risk of cardiovascular complications in patients with frequent hypertensive crises
by: Igor' Petrovich Kolos, et al.
Published: (2009-09-01)

Association of uncontrolled blood pressure in apparent treatment‐resistant hypertension with increased risk of major adverse cardiovascular events plus
by: George Bakris, et al.
Published: (2023-08-01)

10-YEAR RISK ESTIMATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HYPERTENSIVE PATIENTS
by: Olha M. Chernatska, et al.
Published: (2021-06-01)

A propensity score matched comparison of blood pressure lowering in essential hypertension patients treated with antihypertensive Chinese herbal Medicine: comparing the real-world registry data vs. randomized controlled trial
by: Xinxing Lai, et al.
Published: (2023-12-01)

The incidence of cardiovascular and cerebrovascular complications in patients with uncontrolled hypertension
by: Anastasiya R. Denisova, et al.
Published: (2022-01-01)

Hypertensive Disorders of Pregnancy and Future Cardiovascular Health
by: Karen Melchiorre, et al.
Published: (2020-04-01)

Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study
by: Weiqiang Wu, et al.
Published: (2023-09-01)

Lifetime risk assessment in cholesterol management among hypertensive patients: observational cross-sectional study based on electronic health record data
by: Aapo Tahkola, et al.
Published: (2020-04-01)

Hypertension, BMI, and cardiovascular and cerebrovascular diseases
by: Qiao Wenjing, et al.
Published: (2021-01-01)

Real‐world clinical practice of pulmonary arterial hypertension in Japan: Insights from a large administrative database
by: Junichi Omura, et al.
Published: (2023-07-01)

Interaction of Blood Pressure and Glycemic Status in Developing Cardiovascular Disease: Analysis of a Nationwide Real‐World Database
by: Yuta Suzuki, et al.
Published: (2023-01-01)

Case report: The role of hypertension retinopathy graduation in the management of systemic cardiovascular disease
by: Kathryn Kosteva, et al.
Published: (2024-01-01)

Diagnostic-Therapeutic Pathway and Outcomes of Early Stage NSCLC: a Focus on EGFR Testing in the Real-World
by: Giulia Pasello, et al.
Published: (2022-06-01)

Association between cardiovascular risk factors and stage 1 hypertension defined by the 2017 ACC/AHA guidelines
by: Xing Zhen Liu, et al.
Published: (2020-08-01)

CARDIOVASCULAR CAUSES OF SYSTEMIC HYPERTENSION
by: Mircea Gelu Buta
Published: (2009-06-01)

Valoración del control del paciente hipertenso Assessment and control of hypertensive patients
by: Katerinne Álvarez González, et al.
Published: (2012-08-01)

Long-term cardiovascular events in hypertensive patients: full report of the Korean Hypertension Cohort
by: Jin Young Lee, et al.
Published: (2023-01-01)

Hypertension in Africa: Redressing the burden of cardiovascular disease using cost-effective nonpharmacological approaches
by: Gavin R. Norton, et al.
Published: (2017-04-01)

Safety of macitentan for the treatment of pulmonary hypertension: Real‐world experience from the OPsumit® USers Registry (OPUS) and OPsumit® Historical USers cohort (OrPHeUS)
by: Vallerie V. McLaughlin, et al.
Published: (2022-10-01)

Dry eye rate and its relationship with disease stage in patients with primary hypertension: a cross-sectional study in Vietnam
by: Tran Tat Thang, et al.
Published: (2024-04-01)

A Real-world Research of Huoxue Sanfeng Acupuncture Intervention on Blood Pressure in Patients with Cerebral Infarction and Hypertension
by: HE Qiuxia, DU Yuzheng, MENG Xianggang, SHI Xuemin
Published: (2022-02-01)

CATESTATIN AS A NOVEL MARKER OF CARDIOVASCULAR RISK IN SYSTEMIC HYPERTENSION
by: E. Yu. Gubareva, et al.
Published: (2018-05-01)

Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
by: Anastasia V. Poznyak, et al.
Published: (2022-08-01)

Early Mortality, Cardiovascular, and Renal Diseases in Women's Lives Following Hypertensive Disorders of Pregnancy: The Prospective Nationwide Study CONCEPTION
by: Grégory Lailler, et al.
Published: (2024-04-01)

Acute and Chronic Effects of Isometric Handgrip Exercise on Cardiovascular Variables in Hypertensive Patients: A Systematic Review
by: Breno Q. Farah, et al.
Published: (2017-08-01)

Effect of flaxseed powder on cardiovascular risk factor in dyslipidemic and hypertensive patients
by: Naemeh Haghighatsiar, et al.
Published: (2019-01-01)

Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES)
by: Katerina R. Kaczmarski, et al.
Published: (2019-04-01)

Hypertensive Disorders of Pregnancy and Cardiovascular Disease Risk Across Races and Ethnicities: A Review
by: Renée J. Burger, et al.
Published: (2022-06-01)

Arterial hypertension, cardiovascular remodeling and plasma level of osteopontin in patients with end-stage kidney disease on hemodialysis
by: V. A. Vizir, et al.
Published: (2014-12-01)